Clarametyx Biosciences

Columbus, United States

Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies.

Jan 2025

Series A

Biotechnology Health Care Medical Pharmaceutical

Top Investors

Rev1 Ventures1776 VenturesCARB-XCystic Fibrosis FoundationJobsOhio

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Clarametyx Biosciences

Who are Clarametyx Biosciences's investors?

Clarametyx Biosciences's investors include Rev1 Ventures, 1776 Ventures, CARB-X, Cystic Fibrosis Foundation, JobsOhio.

Where is Clarametyx Biosciences headquartered?

Clarametyx Biosciences is headquartered in Columbus, United States.

What does Clarametyx Biosciences do?

Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies.

What stage is Clarametyx Biosciences at?

Clarametyx Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 28, 2025.

MLA

"Clarametyx Biosciences — Funding & Investors." VCBacked, January 28, 2025, https://www.vcbacked.co/company/clarametyx-biosciences. Accessed June 17, 2026.

APA

VCBacked. (2025). Clarametyx Biosciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/clarametyx-biosciences

Wikipedia (cite web)

{{cite web |title=Clarametyx Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/clarametyx-biosciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 28, 2025.